As for the impacts of valsartan and tripterygium glycosides on TLR4 expression, a related study has reported that valsartan prevents glycerol-stimulated acute kidney injury via reducing the TLR4 and NF-kappaB expression [24]. Here, TLR4 is linked to acute kidney injury.